The pathogenic role of VEGF in tumour growth is well documented (reviewed in [17]) and not only has enhanced VEGF expression been observed in all forms of NSCLC, but also high serum levels have been correlated with poor prognosis in patients [27, 28]. Here, VEGFA is linked to non-small cell lung carcinoma.